Pablo Fernandez-Peñas

45PUBLICATIONS
114CO-AUTHORS
AllergyEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 21, 2026
Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study.

|May 21, 2026
Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.

|Mar 10, 2026
Management of Treatment Resistant EGFR Inhibitor-Induced Papulopustular Exanthema With Isotretinoin and Dapsone.

Ishana Dixit, Raquel Ruiz Araujo, Pablo Fernandez-Peñas

|Dec 31, 2025
Factors to Predict 13 or More Sections in Mohs Micrographic Surgery.

Gilberto Moreno Bonilla, Vendula Blaya-Novakova, Thomas Jonathan Stewart

|Dec 26, 2025
A protocol for development of a microsimulation model platform to evaluate the potential benefits, harms, and cost-effectiveness of risk-tailored melanoma screening.

Kirstie G McLoughlin, Caroline G Watts, Stephen Wade

|Nov 03, 2025
Reliability of Clinical Scoring Tools in Teledermatology Compared to Face-To-Face Assessment: A Systematic Review and Meta-Analysis.

Kelvin Truong, William Luu, Pablo Fernandez-Penas

Pageof 8

Frequent Collaborators

5 joint publications

Kelvin Truong

4 joint publications

Ali Azimi

3 joint publications

Victoria L Venning

3 joint publications

Hans Peter Soyer